Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 59.09M P/E - EPS this Y -29.70% Ern Qtrly Grth -
Income -18.95M Forward P/E -0.79 EPS next Y 45.80% 50D Avg Chg -3.00%
Sales 18.11M PEG - EPS past 5Y - 200D Avg Chg -4.00%
Dividend N/A Price/Book 0.70 EPS next 5Y - 52W High Chg -36.00%
Recommedations 2.00 Quick Ratio 3.50 Shares Outstanding 44.16M 52W Low Chg 50.00%
Insider Own 4.19% ROA -11.06% Shares Float 12.71M Beta 0.52
Inst Own 27.85% ROE -24.66% Shares Shorted/Prior 15.08K/13.69K Price 1.35
Gross Margin 100.00% Profit Margin -104.61% Avg. Volume 25,998 Target Price 12.00
Oper. Margin -2,288.81% Earnings Date Mar 28 Volume 18,678 Change -1.46%
About Adagene Inc.

Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti- CD137 IgG4 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a masked fully-human anti-CTLA-4 mAb that is in Phase 1 clinical trial for the treatment advanced/metastatic solid tumors; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase 1b/2 clinical development for the treatment of advanced/metastatic solid tumors. It also offers ADG104, an anti-PD-L1 mAb that is in Phase 2 clinical development; ADG125, a novel anti-CSF-1R mAb, which is in Phase I clinical trial; ADG206, a masked, Fc engineered anti-CD137 agonistic POWERbody; ADG153, a masked anti-CD47 IgG1 SAFEbody, which is in preclinical for the treatment hematologic and solid tumors; ADG138, novel HER2xCD3 POWERbody, which is in preclinical for the treatment HER2-expressing solid tumors; and ADG152, a v POWERbody, which is in preclinical stage for the treatment off-tumor toxicities, as well as develops anti-CD28 bispecific POWERbody TCEs. The company was incorporated in 2011 and is headquartered in Suzhou, China.

Adagene Inc. News
03/29/24 Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update
03/07/24 Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board
02/27/24 Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
02/09/24 Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
01/17/24 Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
01/10/24 Adagene Inc.'s (NASDAQ:ADAG) market cap surged US$34m last week, retail investors who have a lot riding on the company were rewarded
01/04/24 Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium
11/03/23 Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023
10/30/23 Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
10/13/23 Are Medical Stocks Lagging Medpace (MEDP) This Year?
10/12/23 Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG126 at Upcoming Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
09/27/23 Is Adagene (ADAG) Outperforming Other Medical Stocks This Year?
09/09/23 Potential Upside For Adagene Inc. (NASDAQ:ADAG) Not Without Risk
09/07/23 Adagene to Present at Investor and Scientific Conferences in September
09/07/23 Are Medical Stocks Lagging Adagene (ADAG) This Year?
08/31/23 Adagene Reports Six Month Financial Results for 2023 and Provides Corporate Update
05/25/23 Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
ADAG Chatroom

User Image peapope Posted - 1 week ago

$ADAG anything going on here??? big volume

User Image Stock_Titan Posted - 03/29/24

$ADAG Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/ADAG/adagene-reports-full-year-2023-financial-results-and-provides-vu90w1exx7nd.html

User Image Scooter0732 Posted - 2 months ago

$ADAG anyone else feel like that leerink interview was odd? Was it a cultural difference but I couldn’t understand how the ctla molecule is dealing with tregs other than ‘it is’ or why they are differentiated from BMY’s recently discontinued ctla that’s masked other than ‘it is’??

User Image Ninja_Tradez Posted - 02/27/24

📢 $ADAG - Adagene to Present at the Leerink Partners Global Biopharma Conference 2024 https://newsfilter.io/a/fde4d1b3cc490cbc36ffa36f40b77e18

User Image Stock_Titan Posted - 02/27/24

$ADAG Adagene to Present at the Leerink Partners Global Biopharma Conference 2024 https://www.stocktitan.net/news/ADAG/adagene-to-present-at-the-leerink-partners-global-biopharma-dvctpvwsomqa.html

User Image Tazdoc88 Posted - 3 months ago

$ADAG

User Image Gmanthemagnificent Posted - 3 months ago

$AGEN mean while $ADAG, garos competitor is green today and up almost 100% over the last year.....

User Image OpenOutcrier Posted - 3 months ago

$ADAG (+4.3% pre) Adagene (ADAG) Announces Progress and Expansion of Clinical Collaboration Program for ADG126 in Combination with KEYTRUDA - SI https://ooc.bz/l/24521

User Image Charlestrader777 Posted - 3 months ago

$ADAG 👀

User Image Stock_Titan Posted - 3 months ago

$ADAG Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC) https://www.stocktitan.net/news/ADAG/adagene-announces-progress-and-expansion-of-clinical-collaboration-2pi98lt17lf5.html

User Image ChartLaboratory_com Posted - 3 months ago

$HRT $PLTR $ADAP $ADAG $BLZE

User Image ChartLaboratory_com Posted - 3 months ago

$PLTR $BLZE $HRT $ADAG $ADAP working to plan 💎 Qu? will they all continue to extend during powerhour? ⭐️ trade ideas and guidance! 💰Experience trading success with real-time trade ideas and guidance! WE provide live alerts for profitable trades. 🥇 miss out on the opportunity to join our winning community. Visit Patreon/chartlab below to become a part of it now 🏆

User Image Moneyyx Posted - 3 months ago

$ADAG I’m new to this. Any news recently?

User Image Gmanthemagnificent Posted - 3 months ago

$AGEN $ADAG was the better play here.

User Image VirmoMopire Posted - 01/30/24

$ADAG Just spotted some interesting activity on this one. 🧐

User Image _www_larval_com_ Posted - 01/25/24

$RVSN 5%[39%] $RENB -3%[7%] $ADAG -3%[8%] $AUVI 3%[14%] $RR -3%[32%] most notable movement into the final minutes of trading.

User Image MITornado Posted - 01/24/24

$ADAG is this data better than $AGEN? Stock price is better but… 🤔

User Image TrendyChart Posted - 01/23/24

$ADAG The canvas of the stock chart is adorned with Bearish strokes, as technical indicators shape a narrative of potential success and strong support. 💹

User Image Gilbert_Jorge Posted - 01/22/24

We called the PERFECT entry for $LYT, securing our FREE trial members a HUGE PROFIT of 106%! Trial Link in Profile 👉 @Gilbert_Jorge $HMST $ADAG

User Image Connor_Julian2 Posted - 4 months ago

After our analyst's entry alert, BBLG went to the MOON- securing our 14-day FREE trial members a 145% gain. Discord Link in Profile 👉 @Connor_Julian2 $HMST $ADAG

User Image TalkMarkets Posted - 4 months ago

Week in Review: Lee’s Pharma Signs $138 Million Agreement For Rights To Heart Failure Therapy $AZN $WINT $ADAG $MRK https://talkmarkets.com/content/global-markets/week-in-review-lees-pharma-signs-138-million-agreement-for-china-rights-to-heart-failure-therapy?post=428232&userid=123969

User Image John_Alex321 Posted - 4 months ago

Our member secured nearly $3000 in profits after trying out our new trading STRATEGY. Learn how make trades like these with the 14-day FREE trial. Trial Link in Profile 👉 @John_Alex321 $HMST $ADAG

User Image 5556_peacock Posted - 4 months ago

$ADAG What Is Short Interest? Short interest is the number of shares that have been sold short and remain outstanding. Traders typically sell a security short if they anticipate that price will decline by borrowing shares of stock. The investor then sells these borrowed shares to buyers willing to pay the market price. Short interest is often an indicator of current market sentiment. An increase in short interest often signals that investors have become more bearish, while a decrease in short interest signals that they have become more bullish. $ADAG SHORT INTEREST HAS DECREASED REVIEW GRAPH :

User Image _www_larval_com_ Posted - 4 months ago

$ADAG just reverted 7% higher to -19% (~145Kv) a few minutes ago, follow for more volatility.

User Image lecorb Posted - 4 months ago

$IRBT AXDX $CISS $ADAG $ASTS Etc.. Bad bad day!

User Image _www_larval_com_ Posted - 4 months ago

$ADAG 9%[-4%] $RNAZ -3%[-48%] $NVNI 3%[52%] $ALAR -3%[-14%] most notable movement into the final minutes of trading.

User Image db5542 Posted - 4 months ago

$ADAG this is some roller coaster ride!

User Image Newguy21 Posted - 4 months ago

$ADAG Money maker today

User Image STCKPRO Posted - 4 months ago

$ADAG NEW ARTICLE : Adagene falls after trial data for cancer therapy https://stck.pro/news/ADAG/72962810/

User Image Prized_Possessions Posted - 4 months ago

$ADAG don’t recall seeing a daily candle like this since March 2020.

Analyst Ratings
HC Wainwright & Co. Buy Oct 4, 23
HC Wainwright & Co. Buy Sep 1, 23
HC Wainwright & Co. Buy Apr 21, 23
HC Wainwright & Co. Buy Mar 29, 23
HC Wainwright & Co. Buy Mar 21, 23
Morgan Stanley Overweight Jan 24, 23
HC Wainwright & Co. Buy Dec 7, 22
Morgan Stanley Overweight Sep 9, 22
Morgan Stanley Overweight Feb 1, 22